Navigation Links
MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
Date:8/23/2007

New Facility Allows MedImmune to Meet Increasing Demands for Clinical Trial

Materials from Company's Expanding and Advancing Pipeline

GAITHERSBURG, Md., Aug. 23 /PRNewswire-FirstCall/ -- MedImmune today unveiled a new, state-of-the-art pilot lab facility located on the same Gaithersburg site as its headquarters. With its cutting-edge equipment and process automation systems, the facility will support MedImmune's expanding clinical product pipeline by providing additional capacity and flexibility.

At a ribbon-cutting event for the pilot lab held today at MedImmune, David M. Mott, president and chief executive officer, stated: "Completing this new facility is an important milestone, signaling our continued growth and success as a world-class biopharmaceuticals company. The opening of this facility, alongside the expansion work underway on our new biologics facility in Frederick, Maryland, reaffirms our leadership role within the state's biotechnology industry and demonstrates our ongoing commitment to the region."

The new pilot lab's 5,000 liters of bioreactor capacity will result in a four-fold increase in production capabilities. With the expanded facility, MedImmune will be able to produce clinical trial materials at a greater scale and in greater quantities, aiding in the testing of potential new products.

"This substantial increase in MedImmune's clinical production infrastructure supports our robust pipeline of product candidates," said Gail Folena-Wasserman, Ph.D., senior vice president, development. "The pilot lab facility is intended to meet our current and future needs, not just through its increased capacity but also through design flexibility, which efficiently allows us to produce multiple clinical products in the same space. We can drive efficiency and meet rigorous quality standards by incorporating the latest technology, including an advanced process control system."

In December 2006, the City of Gaithersburg approved the new pilot lab facility for occupancy. The facility will become the primary site for production of MedImmune's therapeutic proteins, replacing the existing Gaithersburg Manufacturing Development Facility (GMDF) where those clinical trial materials are currently produced. Material production is expected to begin in 2008, following the final stages of equipment validation. MedImmune plans to upgrade GMDF in the near future to provide added support for its development needs.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The Why Files celebrates decade of science exploration
2. Young Professionals of Milwaukee Celebrates Its Third Birthday, Looks To The Future
3. Internet Scout celebrates 10 years on web, eyes new project launch
4. Farm Aid celebrates 20-year journey, heads back to Illinois roots
5. UW Office of Corporate Relations Celebrates Early Accomplishments
6. Its All Fun And Games in Madison - Raven Software Celebrates 15 Anniversary
7. Merge files financial reports by market opening
8. RFID pilot project aims to improve blood banks
9. Pilot fund brings capital to Eau Claire area innovations
10. National $100m pilot program to begin mapping cancer genome
11. Milwaukee health provider network pilots software plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):